Company

Marengo Therapeutics, Inc.

Marengo Therapeutics, Inc., founded in 2015 in Cambridge, develops TCR-targeting antibodies to fight cancer.

About

Founded in 2015 and headquartered in Cambridge, US, Marengo Therapeutics, Inc. develops first-in-class TCR-targeting antibodies designed to activate the immune system against cancers. Zhen Su is the CEO. Its latest funding round was a USD 80 mn Seed round led by Apple Tree Partners on November 8, 2021, and the company has completed 2 deals.

2Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in